Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C

George Cholankeril1, Ryan B Perumpail2, Menghan Hu3

  • 1Department of Internal Medicine, Roger Williams Medical Center, Boston University School of Medicine, 825 Chalkstone Avenue, Providence, RI, 02908, USA. gcholankeril@gmail.com.

Insights

Chronic hepatitis B (HBV) and hepatitis C (HCV) infections cause significant inpatient costs and resource use. HBV hospitalizations show higher mortality and longer stays than HCV, highlighting the need for early HBV diagnosis and care.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Health Economics

Background:

  • Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) are major causes of chronic liver disease and liver cancer.
  • Current healthcare initiatives aim for early diagnosis and linkage to care to reduce costs associated with advanced liver disease.

Purpose of the Study:

  • To evaluate the impact of liver complications from chronic HBV and HCV on inpatient costs, length of stay, and mortality.
  • To compare resource utilization between HBV and HCV related hospitalizations.

Main Methods:

  • Utilized the Healthcare Cost and Utilization Project, National Inpatient Sample (HCUP-NIS) database.
  • Analyzed inpatient data from 2003 to 2012 for adult patients in the USA.
  • Compared HBV and HCV related hospitalizations regarding cost, length of stay, and mortality.

Main Results:

  • HBV infections accounted for 0.18% and HCV for 1.36% of all hospitalizations studied.
  • HBV hospitalizations had higher inpatient mortality (OR 1.34), increased median cost (+$2100.33), and longer stays (+0.64 days) compared to HCV.
  • p < 0.01 for increased length of stay.

Conclusions:

  • Despite higher per-case resource utilization, HBV patients exhibit lower inpatient survival than HCV patients.
  • These findings emphasize the critical need for early diagnosis of chronic HBV infection in at-risk populations.
  • Prompt linkage to care for HBV is essential to improve outcomes and manage healthcare costs.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
27
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
254
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
333
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
467
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
896
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.8K